Diagnosis and treatment in hereditary hemochromatosis;Diagnostik und therapie der hereditären hämochromatose

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 50, 2009, Pages 2565-2572

  Figura, G Von ^a   Kulaksiz, H ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cirrhosis; Genetic testing; Hemochromatosis; HFE; Iron

Indexed keywords

DICLOFENAC;

ABDOMEN; ADULT; ANAMNESIS; ARTHRALGIA; CASE REPORT; CLINICAL EXAMINATION; DIAGNOSTIC PROCEDURE; DYSPNEA; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; MALE; ORTHOPEDICS; PATHOPHYSIOLOGY; PHYSICIAN; REVIEW; RHEUMATOLOGY;

FEMALE; GENETIC TESTING; HEMOCHROMATOSIS; HUMANS; JOINTS; LIVER; MALE; MIDDLE AGED; MYOCARDIUM; PANCREAS;

EID: 72849140639     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1243062     Document Type: Review

References (28)

1. Adams P C., Barton J C. Haemochromatosis. Lancet 2007 370 1855-1860
2. Adams P C., Reboussin D M., Barton J C., et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005 352 1769-1778
3. Aguilar-Martinez P, Bismuth M, Picot M C., et al. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 2001 48 836-842
4. Alexander J, Kowdley K V. HFE-associated hereditary hemochromatosis. Genet Med 2009 11 307-313
5. Allen K J., Gurrin L C., Constantine C C., et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008 358 221-230
6. Barton J C., McDonnell S M., Adams P C., et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 1998 129 932-939
7. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996 22 187-194; discussion 194a-194b
8. Camaschella C, Poggiali E. Towards explaining unexplained hyperferritinemia. Haematologica 2009 94 307-309
9. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000 25 14-15
10. Elmberg M, Hultcrantz R, Ekbom A, et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003 125 1733-1741 (Pubitemid 37500438)
11. Erhardt A, Häussinger D. Hämochromatosen Hämosiderosen. 1. ed. Bremen UNI-MED Verlag AG 2006
12. Feder J N., Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996 13 399-408
13. Imran F, Phatak P. Pharmacoeconomic benefits of deferasirox in the management of iron overload syndromes. Expert Rev Pharmacoecon Outcomes Res 2009 9 297-304
14. Kowdley K V., Trainer T D., Saltzman J R., et al. Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. Gastroenterology 1997 113 1270-1277
15. Kulaksiz H, Gehrke S G., Janetzko A, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 2004 53 735-743
16. Leitlinien der Deutschen Gesellschaft für Humangenetik und des Berufsverbands Deutscher Humangenetiker: Molekulargenetische Diagnostik der hereditären Hämochromatose, in: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF): http://www. leitlinien.net/; 12/1997, updated 08/2006
17. Merryweather-Clarke A T., Pointon J J., Shearman J D., Robson K J. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997 34 275-278
18. Nemeth E, Tuttle M S., Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004 306 2090-2093
19. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996 110 1107-1119
20. Njajou O T., Vaessen N, Joosse M, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001 28 213-214
21. Papanikolaou G, Samuels M E., Ludwig E H., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004 36 77-82
22. Pietrangelo A. Hereditary hemochromatosis a new look at an old disease. N Engl J Med 2004 350 2383-2397
23. Rochette J, Pointon J J., Fisher C A., et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 1999 64 1056-1062
24. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003 33 21-22
25. Schumacher H R., Straka P C., Krikker M A., Dudley A T. The arthropathy of hemochromatosis. Recent studies. Ann N Y Acad Sci 1988 526 224-233
26. Sharp P, Srai S K. Molecular mechanisms involved in intestinal iron absorption. World J Gastroenterol 2007 13 4716-4724
27. Summers K M., Halliday J W., Powell L W. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990 12 20-25
28. Yu L, Ioannou G N. Survival of liver transplant recipients with hemochromatosis in the United States. Gastroenterology 2007 133 489-495